logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Kien Hung

viet nam national cancer hospital
H指数:4
被引数:64

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Savolitinib Plus Osimertinib in Epidermal Growth Factor-Mutated, MET-Amplified Advanced Non-Small Cell Lung Cancer: A Randomized Phase 2 trial

Savolitinib 联合 Osimertinib 治疗表皮生长因子突变、MET 扩增的晚期非小细胞肺癌：一项随机 II 期临床试验

Clinical Lung Cancer
IF3.3
2025-10-220
PRE
James Chih-Hsin Yang; Yuh-Min Chen; Ullas Batra; Kien Hung Do; Piyada Sitthideatphaiboon; Pongwut Danchaivijitr; KangYun Lee; Jarin Chindaprasirt; Cheng-Ta Yang; GeeChen Chang; Chaiyut Charoentum; Teerapat Ungtrakul; Juan Ignacio Hernandez Moran; Ryan Hartmaier; Ike Igwegbe; Alexander Gont; Matthew Haskins; Wanning Xu; Jonathan W. Riess
Optimizing afatinib dosage: enhancing treatment outcomes and minimizing toxicities in advanced EGFR-mutated non-small cell lung cancer patients in Vietnam

优化阿法替尼剂量：增强越南晚期EGFR突变非小细胞肺癌患者的治疗效果并减少毒性

Therapeutic Advances in Medical Oncology
IF4.2
2025-10-140
OA
Cam Phuong Pham; Hung Kien Do; Anh Tu Do; Tuan Khoi Nguyen; Thi Anh Thu Hoang; Tuan Anh Le; Dinh Thy Hao Vuong; Dac Nhan Tam Nguyen; Van Khiem Dang; Thi Oanh Nguyen; Van Luan Pham; Minh Hai Nguyen; Thi Thai Hoa Nguyen; Thi Bich Phuong Nguyen; Ha Thanh Vu; Thi Thuy Hang Nguyen; Van Thai Pham; Le Huy Trinh; Khac Dung Nguyen; Hoang Gia Nguyen; Cong Minh Truong; Tran Minh Chau Pham; Van Tai Nguyen
Excellent survival benefit achieved in patients with advanced-stage non-small cell lung cancer harboring the epidermal growth factor receptor-G719X mutation treated by afatinib: the real-world data from a multicenter study in Vietnam

使用阿法替尼治疗携带表皮生长因子受体-G719X突变晚期非小细胞肺癌患者取得显著生存获益：来自越南多中心研究的真实世界数据

therapeutic advances in musculoskeletal disease
IF3
2025-05-240
OA
Van Luan Pham; Cam Phuong Pham; Thi Thai Hoa Nguyen; Tuan Khoi Nguyen; Minh Hai Nguyen; Thi Anh Thu Hoang; Tuan Anh Le; Dinh Thy Hao Vuong; Dac Nhan Tam Nguyen; Van Khiem Dang; Thi Oanh Nguyen; Hung Kien Do; Ha Thanh Vu; Thi Thuy Hang Nguyen; Van Thai Pham; Le Huy Trinh; Hoang Gia Nguyen; Cong Minh Truong; Tran Minh Chau Pham; Thi Bich Phuong Nguyen
Real-world analysis of afatinib as a first-line treatment for patients with advanced stage non-small-cell lung cancer with uncommon EGFR mutations: a multicenter study in Vietnam

afatinib作为一线治疗EGFR突变的晚期非小细胞肺癌患者的真实世界分析: 越南的一项多中心研究

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2024-05-091
OAAI
Pham, Van Luan; Le, Tuan Anh; Pham, Cam Phuong; Nguyen, Thi Thai Hoa; Do, Anh Tu; Nguyen, Tuan Khoi; Nguyen, Minh Hai; Hoang, Thi Anh Thu; Vuong, Dinh Thy Hao; Nguyen, Dac Nhan Tam; Dang, Van Khiem; Nguyen, Thi Oanh; Vo, Thi Huyen Trang; Do, Hung Kien; Vu, Ha Thanh; Nguyen, Thi Thuy Hang; Pham, Van Thai; Trinh, Le Huy; Nguyen, Khac Dung; Nguyen, Hoang Gia; Truong, Cong Minh; Pham, Tran Minh Chau; Nguyen, Thi Bich Phuong
A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam

越南EGFR突变晚期非小细胞肺癌患者一线阿法替尼的真实世界队列研究

BMC CANCER
IF3.4
2024-02-052
OAAI
Pham, Cam Phuong; Nguyen, Thi Thai Hoa; Do, Anh Tu; Nguyen, Tuan Khoi; Hoang, Thi Anh Thu; Le, Tuan Anh; Vuong, Dinh Thy Hao; Nguyen, Dac Nhan Tam; Dang, Van Khiem; Nguyen, Thi Oanh; Pham, Van Luan; Nguyen, Minh Hai; Vo, Thi Huyen Trang; Do, Hung Kien; Vu, Ha Thanh; Nguyen, Thi Thuy Hang; Pham, Van Thai; Trinh, Le Huy; Nguyen, Khac Dung; Nguyen, Hoang Gia; Truong, Cong Minh; Pham, Tran Minh Chau; Nguyen, Thi Bich Phuong

研究方向

暂未获取到该数据
C
Cẩm Phương Phạm
H 指数:4论文数:39被引数:111
V
Văn Luận Phạm
H 指数:3论文数:15被引数:32
V
Van Thai Pham
H 指数:4论文数:26被引数:62
C
Cong Minh Truong
H 指数:3论文数:23被引数:26
H
Ha Thanh Vu
H 指数:3论文数:19被引数:353
Đ
Đình Thy Hảo Vương
H 指数:3论文数:9被引数:11
T
Thi Thuy Hang Nguyen
H 指数:5论文数:52被引数:213
T
Thi Thai Hoa Nguyen
H 指数:3论文数:16被引数:21
T
Tuan Khoi Nguyen
H 指数:3论文数:13被引数:14
T
Thị Anh Thư Hoàng
H 指数:3论文数:13被引数:11